XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Revenue from collaboration agreements - Summary of revenue from collaboration agreements (Detail) - EUR (€)
€ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disclosure Of Revenue From Collaboration Agreements [Line Items]        
Revenue from collaboration agreements € 17,215 € 5,189 € 120,123 € 12,592
Amgen        
Disclosure Of Revenue From Collaboration Agreements [Line Items]        
Revenue from collaboration agreements 0 260 0 517
Genmab        
Disclosure Of Revenue From Collaboration Agreements [Line Items]        
Revenue from collaboration agreements 4,125 2,105 7,044 4,341
BMS        
Disclosure Of Revenue From Collaboration Agreements [Line Items]        
Revenue from collaboration agreements 12,107 1,297 110,532 4,590
GSK        
Disclosure Of Revenue From Collaboration Agreements [Line Items]        
Revenue from collaboration agreements 983 1,527 2,547 3,144
Total        
Disclosure Of Revenue From Collaboration Agreements [Line Items]        
Revenue from collaboration agreements € 17,215 € 5,189 € 120,123 € 12,592